✦ LIBER ✦

Phase II Trial of Busulfan-Based Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed By Reduced Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma

✍ Scribed by Chen, Yi-Bin; Li, Shuli; Del Rio, Candice; Driscoll, Jessica; Sadrzadeh, Hossein; Abramson, Jeremy S.; Armand, Philippe; Barnes, Jeffrey; Cutler, Corey S.; Fisher, David C.; Ho, Vincent T.; Hochberg, Ephraim; McAfee, Steven L.; Takvorian, Ronald; Antin, Joseph H.; Soiffer, Robert J.; Jacobsen, Eric

Book ID: 122164943
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 220 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.12.088

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced-dose craniospinal radiotherapy f

Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma

✍ Sung, K. W.; Lim, D. H.; Son, M. H.; Lee, S. H.; Yoo, K. H.; Koo, H. H.; Kim, J. 📂 Article 📅 2012 🏛 Duke University Press 🌐 English ⚖ 135 KB

Chemotherapy with rituximab followed by

Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

✍ Catherine Thieblemont; Daciana Antal; Laurence Lacotte-Thierry; Vincent Delwail; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

## Abstract ## BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by high‐dose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). ## METHODS This was a retrospective analysis of 34 patients who were tre

Phase II Trial of High-Dose Rituximab wi

Phase II Trial of High-Dose Rituximab with Thiotepa/Busulfan/Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma

✍ Chen, Yi-Bin; Batchelor, Tracy; Hochberg, Ephraim; Brezina, Mark; Coughlin, Erin 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 119 KB

185: Feasibility of autologous stem cell

185: Feasibility of autologous stem cell transplant followed by reduced intensity allogeneic stem cell transplantation for high risk neuroblastoma: A single institution pilot study

✍ D.J. Yamashiro; A. Lee; M. Bhatia; J. Glade-Bender; E. Qualter; O. Militano; L.A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB

High Dose Chemotherapy (HDT) with Busulf

High Dose Chemotherapy (HDT) with Busulfan, Melphalan and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Pediatric Patients (pts) with High Risk Solid Tumors

✍ A.B. Pawlowska; J.A. Wolfson; J. Cheng; A. Sorrell; J. Sato; C. Anderson; D. Hit 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Phase II Trial of Reduced Intensity Busu

Phase II Trial of Reduced Intensity Busulfan / Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with AML, MDS, and ALL

✍ Chen, Yi-Bin; Li, Shuli; Del Rio, Candice; Coughlin, Erin; Ballen, Karen K.; Cut 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 124 KB